Literature DB >> 7637010

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France.

I Loussert-Ajaka1, M L Chaix, B Korber, F Letourneur, E Gomas, E Allen, T D Ly, F Brun-Vézinet, F Simon, S Saragosti.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) nucleotide sequences encoding p24Gag and the Env C2V3 region were obtained from seven patients who were selected on the basis of having paradoxical seronegativity on a subset of HIV enzyme-linked immunosorbent assay detection kits and having atypical Western blot (immunoblot) reactivity. Sequence analyses showed that all of these strains were more closely related to the recently described Cameroonian HIV isolates of group O (HIV-1 outlier) than to group M (HIV-1 major). All seven patients had Cameroonian origins but were living in France at the time the blood samples were taken. Characterization of a large number of group M strains has to date revealed eight distinct genetic subtypes (A to H). Genetic distances between sequences from available group O isolates were generally comparable to those observed in M intersubtype sequence comparisons, showing that the group O viruses are genetically very diverse. Analysis of sequences from these seven new viral strains, combined with the three previously characterized group O strains, revealed few discernable phylogenetic clustering patterns among the 10 patients' viral sequences. The level of diversity among group O sequences suggests that they may have a comparable (or greater) age than the M group sequences, although for unknown reasons, the latter group dispersed first and is the dominant lineage in the pandemic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637010      PMCID: PMC189421     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Isolation of atypical HIV-1-related retrovirus from AIDS patient.

Authors:  H Agut; D Candotti; B Rabanel; J M Huraux; G Remy; D Ingrand; T Tabary; C Chippaux; S Chamaret; D Guetard
Journal:  Lancet       Date:  1992-09-12       Impact factor: 79.321

2.  Genetic variants of HIV-1 in Thailand.

Authors:  F E McCutchan; P A Hegerich; T P Brennan; P Phanuphak; P Singharaj; A Jugsudee; P W Berman; A M Gray; A K Fowler; D S Burke
Journal:  AIDS Res Hum Retroviruses       Date:  1992-11       Impact factor: 2.205

3.  Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1.

Authors:  F E McCutchan; B L Ungar; P Hegerich; C R Roberts; A K Fowler; S K Hira; P L Perine; D S Burke
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

Review 4.  The role of the V3 loop of gp120 in HIV infection.

Authors:  J P Moore; P L Nara
Journal:  AIDS       Date:  1991       Impact factor: 4.177

5.  HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate.

Authors:  U Dietrich; M Grez; H von Briesen; B Panhans; M Geissendörfer; H Kühnel; J Maniar; G Mahambre; W B Becker; M L Becker
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

6.  Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand.

Authors:  H Ichimura; S C Kliks; S Visrutaratna; C Y Ou; M L Kalish; J A Levy
Journal:  AIDS Res Hum Retroviruses       Date:  1994-03       Impact factor: 2.205

7.  In vivo genetic variability of the human immunodeficiency virus type 2 V3 region.

Authors:  E Boeri; A Giri; F Lillo; G Ferrari; O E Varnier; A Ferro; S Sabbatani; W C Saxinger; G Franchini
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Signature pattern analysis: a method for assessing viral sequence relatedness.

Authors:  B Korber; G Myers
Journal:  AIDS Res Hum Retroviruses       Date:  1992-09       Impact factor: 2.205

9.  Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.

Authors:  A Benjouad; J C Gluckman; H Rochat; L Montagnier; E Bahraoui
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding.

Authors:  Y Li; L Luo; N Rasool; C Y Kang
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more
  35 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  The molecular population genetics of HIV-1 group O.

Authors:  Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Alexei J Drummond; David L Robertson; Pierre Roques; Michael Worobey; Anne-Mieke Vandamme
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

4.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.

Authors:  Said Zouhair; Sylvie Roussin-Bretagne; Alain Moreau; Sylvie Brunet; Syria Laperche; Michèle Maniez; Francis Barin; Martine Harzic
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  HIV-1 group O virus identified for the first time in the United States.

Authors:  M A Rayfield; P Sullivan; C I Bandea; L Britvan; R A Otten; C P Pau; D Pieniazek; S Subbarao; P Simon; C A Schable; A C Wright; J Ward; G Schochetman
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

7.  Recent aspects of HIV and HIV-related diseases.

Authors:  L Gürtler
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

8.  Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

Authors:  E Randall Lanier; Roger G Ptak; Bernhard M Lampert; Laurie Keilholz; Tracy Hartman; Robert W Buckheit; Marie K Mankowski; Mark C Osterling; Merrick R Almond; George R Painter
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

9.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

10.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.